These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7892412)

  • 1. Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.
    Holtzman SG; Steinfels GF
    Psychopharmacology (Berl); 1994 Nov; 116(3):243-8. PubMed ID: 7892412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of the discriminative stimulus effects of spiradoline.
    Holtzman SG
    Pharmacol Biochem Behav; 2000 Jul; 66(3):517-22. PubMed ID: 10899364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.
    Holtzman SG; Cook L; Steinfels GF
    Psychopharmacology (Berl); 1991; 105(4):447-52. PubMed ID: 1663252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing spiradoline-like discriminative effects of DuP 747: influence of route of administration.
    Holtzman SG; Steinfels GF; Schmidt WK
    Pharmacol Biochem Behav; 1994 Mar; 47(3):487-91. PubMed ID: 8208766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus and response rate-decreasing effects of kappa opioids: antagonism by naloxone.
    Picker MJ
    Life Sci; 1994; 54(23):1767-75. PubMed ID: 8196490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
    Carey GJ; Bergman J
    J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.
    Bronson ME; Lin YP; Burchett K; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 1993; 111(1):69-77. PubMed ID: 7870936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
    Holtzman SG
    Pharmacol Biochem Behav; 1993 Feb; 44(2):349-55. PubMed ID: 8446667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist.
    Holtzman SG; Steinfels GF
    Pharmacol Biochem Behav; 1994 Mar; 47(3):575-8. PubMed ID: 8208776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys.
    Butelman ER; Ball JW; Kreek MJ
    Psychopharmacology (Berl); 2002 Oct; 164(1):115-20. PubMed ID: 12373425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H.
    Mori T; Yoshizawa K; Nomura M; Isotani K; Torigoe K; Tsukiyama Y; Narita M; Suzuki T
    Addict Biol; 2012 Jul; 17(4):717-24. PubMed ID: 21392175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
    Zhang L; Walker EA; Sutherland J; Young AM
    Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects on enadoline in pigeons.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1996 May; 277(2):960-7. PubMed ID: 8627579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.